Industry Urged to Involve Patients Early, Solicit Input on PROs

Device and drugmakers need to engage patients earlier in the development process to ensure they are addressing symptoms and measuring outcomes that matter to patients, patient advocates say. “You want the [patient] perspective early and you want it often,” Marc Boutin, executive vice president and chief operating officer at the National Health Council, said at a recent FDA public hearing to gather input on how patients perceive benefits and risks associated with medical products.
Clinical Trials Advisor